Fausti SA - Search Results

1

Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.

Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS, Bratt GW, Fausti SA. Konrad-Martin D, et al. Among authors: fausti sa. J Am Acad Audiol. 2010 May;21(5):301-14; quiz 357. doi: 10.3766/jaaa.21.5.3. J Am Acad Audiol. 2010. PMID: 20569665 Free PMC article.

2

Early detection of ototoxicity using 1/6th-octave steps.

Fausti SA, Helt WJ, Phillips DS, Gordon JS, Bratt GW, Sugiura KM, Noffsinger D. Fausti SA, et al. J Am Acad Audiol. 2003 Oct;14(8):444-50. J Am Acad Audiol. 2003. PMID: 14655957

3

Evaluation of insert earphones for high-frequency bedside ototoxicity monitoring.

Gordon JS, Phillips DS, Helt WJ, Konrad-Martin D, Fausti SA. Gordon JS, et al. Among authors: fausti sa. J Rehabil Res Dev. 2005 May-Jun;42(3):353-61. doi: 10.1682/jrrd.2004.06.0093. J Rehabil Res Dev. 2005. PMID: 16187247 Free article.

4

Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.

Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D. Reavis KM, et al. Among authors: fausti sa. Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99. Ear Hear. 2008. PMID: 18753950 Clinical Trial.

5

Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Reavis KM, McMillan G, Austin D, Gallun F, Fausti SA, Gordon JS, Helt WJ, Konrad-Martin D. Reavis KM, et al. Among authors: fausti sa. Ear Hear. 2011 Feb;32(1):61-74. doi: 10.1097/AUD.0b013e3181e8b6a7. Ear Hear. 2011. PMID: 20625302 Free PMC article.

6

Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.

Dille MF, Konrad-Martin D, Gallun F, Helt WJ, Gordon JS, Reavis KM, Bratt GW, Fausti SA. Dille MF, et al. Among authors: fausti sa. J Am Acad Audiol. 2010 Jun;21(6):409-17. doi: 10.3766/jaaa.21.6.6. J Am Acad Audiol. 2010. PMID: 20701838 Free PMC article.

7

Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.

Dille MF, McMillan GP, Reavis KM, Jacobs P, Fausti SA, Konrad-Martin D. Dille MF, et al. Among authors: fausti sa. J Acoust Soc Am. 2010 Sep;128(3):1163-74. doi: 10.1121/1.3473693. J Acoust Soc Am. 2010. PMID: 20815453

8

Age-related changes in the auditory brainstem response.

Konrad-Martin D, Dille MF, McMillan G, Griest S, McDermott D, Fausti SA, Austin DF. Konrad-Martin D, et al. Among authors: fausti sa. J Am Acad Audiol. 2012 Jan;23(1):18-35; quiz 74-5. doi: 10.3766/jaaa.23.1.3. J Am Acad Audiol. 2012. PMID: 22284838 Free PMC article.

9

Development and validation of a cisplatin dose-ototoxicity model.

Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D. Dille MF, et al. Among authors: fausti sa. J Am Acad Audiol. 2012 Jul-Aug;23(7):510-21. doi: 10.3766/jaaa.23.7.3. J Am Acad Audiol. 2012. PMID: 22992258 Free PMC article.

10

Intrasubject reliability of high-frequency (9-14 kHz) thresholds: tested separately vs. following conventional-frequency testing.

Fausti SA, Henry JA, Hayden D, Phillips DS, Frey RH. Fausti SA, et al. J Am Acad Audiol. 1998 Apr;9(2):147-52. J Am Acad Audiol. 1998. PMID: 9564678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page